Evidence map›Paper›PMID 34307837›Full record

ArticleAdvanced therapeutics2020

Engineering the Architecture of Elastin-Like Polypeptides: From Unimers to Hierarchical Self-Assembly.

Soumen Saha, Samagya Banskota, Stefan Roberts, Nadia Kirmani, Ashutosh Chilkoti

Abstract read
In one paragraph

Article in Advanced therapeutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Contribution of the ELRs to the development of advancedFrontiers in bioengineering and biotechnology · 2024
    Review
  20. Modular Design for Proteins Assembling into Antifouling Coatings: Case of Gold Surfaces.Langmuir : the ACS journal of surfaces and colloids · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Soumen SahaDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Samagya BanskotaDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Stefan RobertsDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
Nadia KirmaniDepartment of Biology, Trinity College of Arts and Sciences, Duke University, Durham, NC 27708, USA.
Ashutosh ChilkotiDepartment of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

Funding

ELASTIN FUSION PROTEINSR01GM061232 · NIGMS · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2000 to 2017
$4.6M
Thermally Targeted Drug Delivery by Elastin BiopolymersR01EB000188 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2002 to 2015
$3.9M
Thermally Triggered Multivalent Targeting of TumorsR01EB007205 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2007 to 2015
$2.7M
Genetically Encoded Smart Biohybrid MaterialsR35GM127042 · NIGMS · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2018 to 2022
$2.2M
Protease Operated Depot for Delivery of GLP-1R01DK091789 · NIDDK · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2012 to 2015
$1.3M
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver CancerUG3CA211232 · NCI · DUKE UNIVERSITY · PI CHAO, NELSON J., CHILKOTI, ASHUTOSH · 2017 to 2018
$785k
Point of Care Testing to Improve Monitoring of LVAD PatientsR21HL141028 · NHLBI · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH, FRANKLIN, AARON · 2018 to 2019
$421k
2-D Diffusion Assay on Polymer Brush for POC Cardiac Infarction DiagnosisR21HL115410 · NHLBI · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2012 to 2013
$413k
Delivery of Peptide Therapeutics by Molecular Release DepotsR21EB009904 · NIBIB · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2010 to 2011
$410k
A novel sustained-release immunotoxin for treatment of glioblastoma multiformeR21CA237705 · NCI · DUKE UNIVERSITY · PI CHILKOTI, ASHUTOSH · 2019 to 2020
$372k
POC 2-D Diffusion Assay for self-monitoring of BNPR41HL123871 · NHLBI · BIOSTEALTH, INC. · PI CHILKOTI, ASHUTOSH · 2014 to 2014
$178k
NCI NIH HHS R21 CA237705NCI NIH HHS UG3 CA211232NHLBI NIH HHS R21 HL115410NHLBI NIH HHS R21 HL141028NHLBI NIH HHS R41 HL123871NIBIB NIH HHS R01 EB000188NIBIB NIH HHS R01 EB007205NIBIB NIH HHS R21 EB009904NIDDK NIH HHS R01 DK091789NIGMS NIH HHS R01 GM061232NIGMS NIH HHS R35 GM127042
6 · The paper itself

Abstract

Well-defined tunable nanostructures formed through the hierarchical self-assembly of peptide building blocks have drawn significant attention due to their potential applications in biomedical science. Artificial protein polymers derived from elastin-like polypeptides (ELPs), which are based on the repeating sequence of tropoelastin (the water-soluble precursor to elastin), provide a promising platform for creating nanostructures due to their biocompatibility, ease of synthesis, and customizable architecture. By designing the sequence and composition of ELPs at the gene level, their physicochemical properties can be controlled to a degree that is unmatched by synthetic polymers. A variety of ELP-based nanostructures are designed, inspired by the self-assembly of elastin and other proteins in biological systems. The choice of building blocks determines not only the physical properties of the nanostructures, but also their self-assembly into architectures ranging from spherical micelles to elongated nanofibers. This review focuses on the molecular determinants of ELP and ELP-hybrid self-assembly and formation of spherical, rod-like, worm-like, fibrillar, and vesicle architectures. A brief discussion of the potential biomedical applications of these supramolecular assemblies is also included.

Indexed as

bioinspired materialselastin-like polypeptideshierarchical self-assemblypartially ordered polypeptidesrecombinant proteins

Identifiers

PMID34307837
PMCPMC8297442

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.